Inclusion Criteria:

- Patients who have advanced hepatocellular carcinoma and plan to undertake concurrent
chemoradiotherapy.

- Patients willing to undergo the study procedure

- Patients who are fully informed about the study and have signed the informed consent
form

Exclusion Criteria:

- Patients (men or women) under 20 years of age

- Patients who have been received any other treatment including TACE, operation, TACI,
systemic chemotherapy, intraarterial chemotherapy, antiangiogenic therapy

- Patients who have hypersensitivity to MR or US contrast agents

- Women who are pregnant, lactating or who are of childbearing potential and have not
had a negative pregnancy test at baseline visit

- Patients not eligible to contrast media injection according to product labeling

- Patients with a contraindication for MRI or CT

- Patients with impaired renal function (e.g. acute renal failure) or patients on
dialysis